Society Aims to Enhance Study of Side Effect Reporting Tool

1/29/2009

ASHP made recommendations on a proposed Food and Drug Administration (FDA) study that will examine the impact of including a toll-free number to report side effects in direct-to-consumer television advertising. The Society’s comments to the FDA aim to improve the usefulness and clarity of information the agency obtains in the study.

Read ASHP’s comments here.